跳至主要内容
临床试验/NCT01223651
NCT01223651终止不适用

Performance of Continuous Glucose Monitoring Systems at Altitude.

The Royal Bournemouth Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
10
试验地点
2
主要终点
Accuracy of continuous glucose monitoring system (CGMS).

研究概览

简要总结

10 healthy volunteers will undergo the controlled lowering of their blood glucose level at sea level and a simulated altitude of 8,000 feet, to test the hypothesis that continuous glucose monitoring system measurement of blood glucose is as accurate at altitude as at sea level.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 18 - 60 years.
  • •No known medical conditions or concomitant medication.

排除标准

  • •Pregnancy.
  • •Marine diving in preceding 24 hours.
  • •Unable to provide written informed consent.

研究组 & 干预措施

CGMS at sea level.

Active Comparator

To assess reliability of continuous glucose monitoring system at sea level whilst subject undergo's a hyperinsulinaemic glucose clamp study.

干预措施: two step hyperinsulinaemic glucose clamp study. (Procedure)

CGMS reliability at simulated 8000 feet.

Active Comparator

To assess reliability of continuous glucose monitoring system at a simulated altitude of 8,000 feet whilst the participant undergo's a hyperinsulinaemic glucose clamp study.

干预措施: two step hyperinsulinaemic glucose clamp study. (Procedure)

结局指标

主要结局

Accuracy of continuous glucose monitoring system (CGMS).

时间窗: One year.

To evaluate the accuracy of CGMS for glucose measurement at altitude (8,000 ft) in healthy volunteers.

次要结局

  • The effect of altitude on the recognition of hypoglycaemic symptoms.(One year.)

研究者

发起方
The Royal Bournemouth Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验